Advertisement

Topics

A Pilot Test of t:Slim X2 With Control-IQ Technology

2017-12-18 10:22:11 | BioPortfolio

Summary

A 36-48 hour admission testing the t:slim X2 with Control-IQ Technology

Description

The objective of the study is for clinical staff to gain experience using the proposed artificial pancreas system named t:slim X2 with Control-IQ Technology and assess usability in a supervised setting prior to initiating home use in a Training protocol.

Study Design

Conditions

Type1 Diabetes Mellitus

Intervention

Tandem t:slim X2 with Control-IQ Technology

Location

University of Virginia Center for Diabetes Technology
Charlottesville
Virginia
United States
22903

Status

Recruiting

Source

University of Virginia

Results (where available)

View Results

Links

Published on BioPortfolio: 2017-12-18T10:22:11-0500

Clinical Trials [3821 Associated Clinical Trials listed on BioPortfolio]

Tandem Predictive Low Glucose Suspend Inpatient Feasibility Study

The goal of this study is to assess the functionality of an integrated predictive low glucose suspend system designed to minimize the incidence and duration of hypoglycemia by suspending i...

Using an Artificial Pancreas System in Older Adult Type 1 Diabetes Mellitus Patients

To demonstrate that a new insulin pump system can prevent low glucose episodes and improve brain function in aged Type 1 diabetes mellitus subjects.

Efficacy of inControl Advice: A Decision Support System (DSS) for Diabetes

The purpose of this study is to reduce the frequency of hypoglycemia and severe hypoglycemic events in subjects who use insulin pens to treat their Type 1 Diabetes Mellitus (T1DM). Hypogly...

The International Diabetes Closed Loop (iDCL) Trial: Main Protocol

The objective of the study is to assess the efficacy and safety of home use of a Control-to-Range (CTR) closed-loop (CL) system.

Adolescence and Diabetes:Can an Automated Closed Loop System Improve Control ?

This study evaluates the use of the FD2 automated closed loop insulin administration in Adolescents with a poor metabolic control . All youth will be treated in a random order by their usu...

PubMed Articles [15974 Associated PubMed Articles listed on BioPortfolio]

Effect Of Non- Surgical Periodontal Treatment On Glycemic Control Among Type 2 Diabetes Mellitus Patients With Periodontitis.

Periodontitis and Diabetes Mellitus are two closely, bidirectional linked disease where periodontitis is a well-known complication of diabetes it is also considered to be a cause for poor glycaemic co...

Increasing prevalence of diabetes mellitus in a developing country and its related factors.

All countries, irrespective of their developmental stage, face an increasing burden of non-communicable diseases including diabetes mellitus. There is substantial evidence of the existence of the gap ...

Vitamin D ratio and glycemic control in individuals with type 2 diabetes mellitus: a systematic review.

Several studies have suggested the role of vitamin D in glycemic metabolism and its potential as adjuvant treatment of type 2 diabetes mellitus. Thus, this review discusses the role of vitamin D in th...

Effects of supportive telephone counseling in the metabolic control of elderly people with diabetes mellitus.

the purpose of this study was to evaluate the efficacy of telephone-based support for the metabolic control of elderly patients with diabetes mellitus.

Simultaneous 3D MR elastography of the in vivo mouse brain.

The feasibility of sample interval modulation (SLIM) magnetic resonance elastography (MRE) for the in vivo mouse brain is assessed, and an alternative SLIM-MRE encoding method is introduced. In SLIM-M...

Medical and Biotech [MESH] Definitions

A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.

Diabetes mellitus induced experimentally by administration of various diabetogenic agents or by PANCREATECTOMY.

A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1).

Urination of a large volume of urine with an increase in urinary frequency, commonly seen in diabetes (DIABETES MELLITUS; DIABETES INSIPIDUS).

A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.

More From BioPortfolio on "A Pilot Test of t:Slim X2 With Control-IQ Technology"

Quick Search
Advertisement

 

Searches Linking to this Trial

Ad Here